Cortisol – The Stress Hormone
Our immunoassay is widely used to measure cortisol in many biological fluids and has been used extensively as a biomarker for stress and to monitor adrenal function.
Reliable, non-invasive methods for the assessment of oxidative stress and chronic inflammation.
In contrast to current medical and insurance practices focused on the treatment of diseases, we seek to provide biomedical researchers and diagnosticians with reliable, non-invasive methods for the assessment of oxidative stress and chronic inflammation and the efficacy of diet, drugs, nutraceuticals, and lifestyle for the prevention of major debilitating diseases.
Our immunoassay is widely used to measure cortisol in many biological fluids and has been used extensively as a biomarker for stress and to monitor adrenal function.
Over 20 GSTs are expressed in humans. They play key roles in Detoxification, Steroid Metabolism, and Oxidative Stress.
Measurement of histamine levels in foods and beverages, and in biofluids is faster and more precise with our immunoassay kit, which does not require derivatization and exhibits extremely low cross reactivities.
Product Categories
9Resources
Research and development is a major part of what we do at Oxford Biomedical Research.
Learn MoreTechnical Service
A recognized leader in the development of the highest quality immunoassay products, particularly in competitive ELISA kits for the quantification of bioactive lipids.
Learn MoreOxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins and antibodies for biomedical research and drug discovery.
Biomarkers of Oxidative Stress
Primary focus on the identification and assay of biomarkers for oxidative stress and chronic inflammation, two major risk factors for multiple diseases.
ProteoMine™
A cost effective tool for removing high abundance proteins for biomarker discovery.
ToxProfiler™
Captures and detects oxidized proteins in blood correlated with organ-specific toxicity and disease.
New Platform Technologies
Toxicoproteomics and Metabolomics applied in new and practical ways for the diagnosis of early onset disease and the prevention of diseases.
Oxford Biomedical Research (OBR) was founded in 1984 by Denis M. Callewaert Ph.D., Professor of Chemistry and the former Director of the Center for Biomedical Research at Oakland University. It is one of 4 biotechnology companies founded by Professor Callewaert. Located in Rochester Hills, MI, the Company markets over 800 products for the biomedical research community.
Oxford Biomedical Research also performs research and development under the auspices of grants and contracts from the National Institute of Health. OBR has developed a large number of collaborations with internationally recognized scientists, has licensed several key technologies and is further developing clinical diagnostic tests in collaboration with faculty from major academic and government research institutions.